Brian Kabot sold $1,040 of MNTS
director at Momentus Inc.. 400 shares at an average of $2.60, traded Dec 1, 2023, filed Dec 5, 2023.
Score components
- +15RoleDirector
- 0Trade size$1k at market
- 0Share of holdings soldSold 9.6% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001781162-23-000064, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 1, 2023 | SOpen-market sale Class A Common Stock10b5-1 | -400 | $2.60 | $1,040 | 3,782 | Dec 5, 2023 |
Related signals
Other insiders at Momentus Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | Momentus Inc. | Chris Hadfield director | $14k 2,000 shares | +133% | |
| 31Weak | Momentus Inc. | Brian Kabot director | $1,379 250 shares | +6% | |
| 33Weak | Momentus Inc. | Brian Kabot director | $9,999 1,850 shares | +128% | |
| 31Weak | Momentus Inc. | Brian Kabot director | $1,404 250 shares | +6% | |
| 31Weak | Momentus Inc. | Chris Hadfield director | $7,980 1,500 shares | - | |
| 0Weak | Momentus Inc. | Brian Kabot director | $1,400 400 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.